来自全球100多家制药和生物技术公司

2005年以来,我们一直在俄罗斯、中东欧国家及欧洲,为全球制药和生物技术客户管理临床试验。

十多年来,我们始终为得到申办者的信任而无比自豪,也时刻保持谦卑。我们提供的全方位CRO服务,帮助全球申办者进行临床试验外包,并将他们的创新疗法推向市场。

我们的申办者来自世界各地的制药和生物技术公司。

申办者对OCT的评价

我们很高兴OCT Clinical能够在规定时间内,满足我们的招募需求,特别是在夏季的时候。

Alexander Khaymenov, MD, Ph.D.
Head of Clinical Research at a Dr. Reddy’s Laboratories’ representative office

We're pleased with the OCT team for having successfully completed our study and achieving patient recruitment target ahead of the schedule.

Luke Oh, Ph.D.
Product Evaluation Team Leader, Samsung Bioepis

We are very pleased with the OCT Clinical team for meeting our recruitment goal under such difficult conditions. The achievement is quite impressive, considering the challenging circumstances imposed by the global pandemic.

BokJin Hyun
Head of Clinical Research, Handok Inc.

We are happy with the results OCT Clinical has been demonstrating as the principal CRO for the project.

Andreas Gerward
CEO, Stayble Therapeutics

We are pleased to once again work with the professional OCT Clinical team as we continue to generate important scientific evidence related to our MED3000 gel.

James Barder
CEO, Futura Medical

如需查看推荐信和我们目前的客户名单,请联系info@oct-clinicaltrials.com

Why Our Clients Choose Us

联系OCT Clinical

Thank you for your request!
Our team will respond to you within 24 hours.